Douglas Kyle Hogarth to Adalimumab
This is a "connection" page, showing publications Douglas Kyle Hogarth has written about Adalimumab.
Connection Strength
0.117
-
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18; 31(1):46-54.
Score: 0.117
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.